Universal-Beteiligungs- und Servicegesellschaft
MYGN icon

Universal-Beteiligungs- und Servicegesellschaft’s Myriad Genetics MYGN Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,735
Closed -$66K – 2117
2025
Q4 		$66K Hold
10,735
– – ﹤0.01% 2033
2025
Q3 		$77.6K Buy
+10,735
New +$63.7K ﹤0.01% 2064

Other funds holding MYGN

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's MYGN Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Myriad Genetics (MYGN) in Q1 2026, closing a stake of 10,735 shares — an estimated $66K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in MYGN in Q3 2025 and held it in 2 quarters. The position peaked at $77.6K in Q3 2025. 203 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Myriad Genetics position as of Q1 2026 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 10,735 Myriad Genetics shares in Q1 2026, an estimated $66K.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Myriad Genetics in Q3 2025 and held it in 2 quarters.
  • Universal-Beteiligungs- und Servicegesellschaft's Myriad Genetics position peaked at $77.6K in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.